Genital Diseases, Female  >>  gemcitabine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT00057928: S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Withdrawn
3
0
US, Canada
cisplatin, gemcitabine hydrochloride, paclitaxel
Southwest Oncology Group, National Cancer Institute (NCI)
Cervical Cancer
07/03
07/03
NCT00191100: Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix

Completed
3
515
RoW
Gemcitabine, LY188011, Gemzar, Cisplatin, Brachytherapy, Pelvic radiation
Eli Lilly and Company
Cancer of Cervix
04/08
04/08
AGO-OVAR9, NCT00052468: Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer

Completed
3
1742
Europe
TCG, Paclitaxel/Carboplatin/Gemcitabine, TC, Paclitaxel/Carboplatin
AGO Study Group, Nordic Society of Gynaecological Oncology - Clinical Trials Unit, GERCOR - Multidisciplinary Oncology Cooperative Group
Fallopian Tube Cancer, Ovarian Cancer
07/09
01/11
NCT00191646: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy

Completed
3
919
US
Gemcitabine, LY188011, Gemzar, Paclitaxel, Carboplatin
Eli Lilly and Company
Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
08/09
08/09
NCT00011986: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Completed
3
4312
US
Paclitaxel, Anzatax, TAX, Carboplatin, Gemcitabine Hydrochloride, dFdC, dFdCyd, Pegylated Liposomal Doxorubicin Hydrochloride, doxorubicin HCl liposome, TLC D-99, Topotecan Hydrochloride, Hycamtin, SKF S-104864-A, TOPO, Therapeutic Conventional Surgery
Gynecologic Oncology Group, Southwest Oncology Group, Medical Research Council, National Cancer Institute (NCI)
Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer
03/10
01/13
OCEANS, NCT00434642: A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma

Checkmark SGO 2014
Mar 2014 - Mar 2014: SGO 2014
Checkmark P3 data-ESMO
Sep 2012 - Sep 2012: P3 data-ESMO
Checkmark P3 data (Ovarian)-OCEANS
More
Completed
3
484
NA
Carboplatin, Gemcitabine, Bevacizumab, Avastin, Placebo
Genentech, Inc.
Ovarian Cancer
09/10
07/13
NCT00064077: Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Completed
3
513
US
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Quality-of-Life Assessment, Quality of Life Assessment, Topotecan Hydrochloride, Hycamptamine, Hycamtin, SKF S-104864-A, Topotecan HCl, topotecan hydrochloride (oral), Vinorelbine Tartrate, Biovelbin, Eunades, KW-2307, Navelbine, Navelbine Ditartrate, NVB, Vinorelbine Ditartrate
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Carcinoma, Stage IVB Cervical Cancer
01/11
01/18
HECTOR, NCT00437307: Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse

Completed
3
550
Europe
Topotecan, Hycamtin
North Eastern German Society of Gynaecological Oncology
Ovarian Cancer
07/13
06/15
PENELOPE, NCT01684878 / 2011-005975-17: Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer

Checkmark Platinum-Resistant Ovarian Cancer
Jun 2016 - Jun 2016: Platinum-Resistant Ovarian Cancer
Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark P2 data
More
Completed
3
208
Europe
Gemcitabine (Chemotherapy), Paclitaxel (Chemotherapy), Pertuzumab, Placebo, Topotecan (Chemotherapy)
Hoffmann-La Roche
Ovarian Cancer
01/15
04/16

Download Options